glp 1 receptor agonists and kidney protection GLP-1 next-generation metabolic hormone therapies in chronic disease GLP-1 receptor agonists and next-generation
Description
Currently, only 11 states cover GLP-1s for weight loss under their state employee health plan, nine states provide coverage under their state Medicaid program, and five states provide coverage under both programs
Even more concerning
Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are emerging glucose-lowering agents primarily used in managing diabetes and obesity
Under these circumstances: 503A pharmacies (state-regulated) may compound drugs for individual patients pursuant to specific United States Pharmacopeia (USP) standards
Learn more about its role in diabetes management.
